Market closedNon-fractional
Ventyx Biosciences/VTYX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Ventyx Biosciences
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
Ticker
VTYX
Sector
Healthcare
Trading on
NASDAQ
Industry
Pharmaceuticals
Headquarters
San Diego, United States
Employees
74
Website
ventyxbio.com
VTYX Metrics
BasicAdvanced
$154M
Market cap
-
P/E ratio
-$3.23
EPS
0.47
Beta
-
Dividend rate
Price and volume
Market cap
$154M
Beta
0.47
Financial strength
Current ratio
22.001
Quick ratio
20.819
Long term debt to equity
3.436
Total debt to equity
3.744
Management effectiveness
Return on assets (TTM)
-35.91%
Return on equity (TTM)
-56.76%
Valuation
Price to book
0.5
Price to tangible book (TTM)
0.5
Price to free cash flow (TTM)
-0.707
Growth
Earnings per share change (TTM)
40.65%
3-year earnings per share growth
-52.64%
What the Analysts think about VTYX
Analyst Ratings
Majority rating from 10 analysts.
VTYX Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$39M
-17.56%
Profit margin
0.00%
NaN%
VTYX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.91
-$0.92
-$0.79
-$0.62
-
Expected
-$0.71
-$0.90
-$0.90
-$0.69
-$0.58
Surprise
27.97%
2.73%
-12.55%
-9.65%
-
VTYX News
AllArticlesVideos
![VENTYX SHAREHOLDER ALERT: Ventyx's (Nasdaq:VTYX) Board is Being Investigated for Insider Trading, Long-term Investors Are Notified to Contact the Firm for Details](https://cdn.snapi.dev/images/v1/n/n/press7-2495958.jpg)
VENTYX SHAREHOLDER ALERT: Ventyx's (Nasdaq:VTYX) Board is Being Investigated for Insider Trading, Long-term Investors Are Notified to Contact the Firm for Details
Accesswire·2 weeks ago
![VENTYX STOCK ALERT: Ventyx's (Nasdaq:VTYX) Board is Being Investigated for Insider Trading, Long-term Investors Are Encouraged to Contact the Firm for Details](https://cdn.snapi.dev/images/v1/7/2/press14-2494524.jpg)
VENTYX STOCK ALERT: Ventyx's (Nasdaq:VTYX) Board is Being Investigated for Insider Trading, Long-term Investors Are Encouraged to Contact the Firm for Details
GlobeNewsWire·2 weeks ago
![VENTYX INVESTOR UPDATE: Ventyx's (Nasdaq:VTYX) Board is Being Investigated for Insider Trading, Long-term Investors Are Urged to Contact the Firm for Details](https://cdn.snapi.dev/images/v1/n/6/press15-2492303.jpg)
VENTYX INVESTOR UPDATE: Ventyx's (Nasdaq:VTYX) Board is Being Investigated for Insider Trading, Long-term Investors Are Urged to Contact the Firm for Details
Accesswire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Ventyx Biosciences stock?
Ventyx Biosciences (VTYX) has a market cap of $154M as of July 06, 2024.
What is the P/E ratio for Ventyx Biosciences stock?
The price to earnings (P/E) ratio for Ventyx Biosciences (VTYX) stock is 0 as of July 06, 2024.
Does Ventyx Biosciences stock pay dividends?
No, Ventyx Biosciences (VTYX) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next Ventyx Biosciences dividend payment date?
Ventyx Biosciences (VTYX) stock does not pay dividends to its shareholders.
What is the beta indicator for Ventyx Biosciences?
Ventyx Biosciences (VTYX) has a beta rating of 0.47. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
![Buy or sell Ventyx Biosciences stock](/_next/image?url=%2Fresources%2Fimages%2Fpromo_phone.png&w=256&q=75)
Buy or sell Ventyx Biosciences stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.